Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.40 |
| ▸ | PTGFR | P43088 | 1/20 | 0.40 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.40 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.40 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20204139 | 0.82 | CYP1A2 (0.47) | CYP1A2CYP2A6AKR1C3L3MBTL1 | |
| SCHEMBL30530 | 0.79 | CYP2C9 (0.51) | AKR1C3CYP2C9MEN1KMT2A | |
| SCHEMBL30528 | 0.79 | CYP2C9 (0.51) | AKR1C3CYP2C9MEN1KMT2A | |
| SCHEMBL3904718 | 0.79 | ALOX5 (0.41) | CYP1A2AKR1C3CYP2C9MEN1KMT2A | |
| Iodide SCHEMBL3761279 | 0.78 | CYP2C9 (0.50) | AKR1C3CYP2C9MEN1KMT2A | |
| SCHEMBL19097596 | 0.77 | LMNA (0.55) | AKR1C3CYP2C9KMT2A | |
| SCHEMBL19097595 | 0.77 | LMNA (0.55) | AKR1C3CYP2C9KMT2A | |
| SCHEMBL17940828 | 0.77 | LMNA (0.48) | AKR1C3L3MBTL1CYP2C9MEN1KMT2A | |
| SCHEMBL480740 | 0.77 | LMNA (0.48) | AKR1C3L3MBTL1CYP2C9MEN1KMT2A | |
| SCHEMBL17238780 | 0.76 | FFAR1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7663301-B2 | for use as robust red organic phosphors | GENERAL ELECTRIC COMPANY (US) | 2010-02-16 | — | — | US | disclosed |
| WO-2006076247-A2 | PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060152149-A1 | Porphyrin compositions | GENERAL ELECTRIC COMPANY (US) | 2006-07-13 | — | — | US | disclosed |
| EP-0062611-B1 | PHOTOPOLYMERISATION PROCESS | CIBA-GEIGY AG (CH) | 1985-04-24 | — | — | EP | disclosed |
| EP-0062611-A2 | Photopolymerisation process | CIBA-GEIGY AG (CH) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060152149-A1 | Porphyrin compositions | ACP1, MMS19, MVD | CYP1A2 2696/4885CYP2A6 2252/4885PDPK1 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.